Glaucoma Diagnosis: First 90 Days

A glaucoma diagnosis can feel overwhelming, but the first 90 days are crucial for understanding your condition, starting treatment, and establishing a plan to protect your vision long term. Early follow-up, regular eye pressure monitoring, and clear communication with your glaucoma specialist can make a significant difference in preserving sight.

Your First 90 Days With Glaucoma: A Step-by-Step Action Plan

Many patients ask me: I have been diagnosed with glaucoma. What do I do now. Here is what I tell them: A glaucoma diagnosis does not mean you are going blind. It means you now have information most people get too late. The next 90 days are the most important window — not because the disease moves fast, but because the habits you build now protect your vision for the next 30 years.

This guide, written by Dr Shibal Bhartiya, tells you exactly what to do, in order.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.


Day 1–7 of Glaucoma Diagnosis: Get the Basics Right

Learn to put in your eye drops correctly

This is the single most important skill you will learn. Studies show that over 60% of patients use eye drops incorrectly — and incorrect technique means the drop misses the eye, or drains immediately into the tear duct and does nothing.

Do this:

Wash your hands. Tilt your head back. Pull your lower eyelid gently down to form a pocket. Hold the bottle above the eye without touching it. Squeeze one drop into the pocket — not onto the eyeball directly. Close your eye gently. Press the inner corner of your eye (near the nose) firmly with one finger for 60 seconds. This blocks the tear duct and keeps the drug in the eye where it belongs. Do not blink vigorously. Do not wipe.

If you use more than one drop type, wait five minutes between them. The first drop dilutes and flushes out the second if you use them together.

Ask your doctor or optometrist to watch you do it once. Ask for a correction if your technique needs adjustment.

Here’s a video demostration:

Set your alarms — and take them seriously

Glaucoma drops work only when taken on time, every day, for life. A single missed day matters less than a pattern of casual delays.

Most drops are once daily, ideally at night. Set a recurring alarm on your phone with a label — “Left eye drop, right eye drop, press corner.” Place the bottle next to your toothbrush. The habit links to the existing habit.

If you use drops twice daily, set both alarms. Never rely on memory alone.

File your papers before they disappear

You walked out of the clinic with reports. Photograph or scan every one of them today — the visual field test, the OCT nerve scan, the IOP readings, the prescription. Put them in a dedicated folder on your phone or email them to yourself with the subject line “Glaucoma Records — [your name].”

You will need these at your next visit, at any second opinion, and if you travel and need emergency eye care. Doctors cannot make good decisions without your baseline.


Week 2–4 of Glaucoma Diagnosis: Build the Follow-Up Structure

Your 30-day appointment is not optional

Glaucoma drops take four to six weeks to show their full pressure-lowering effect. Your doctor needs to see you at 30 days to measure whether the drop is working — and to catch side effects early. Do not skip this.

At this visit, your doctor will check:

  • Your intraocular pressure (IOP) against your baseline
  • Whether the drop is causing redness, allergy, or discomfort
  • Whether you need a dose adjustment or a switch to a different medication

Set a calendar reminder for this appointment the day you are diagnosed. If the appointment was not scheduled, call the clinic and schedule it yourself before the week is over.

Know what side effects to watch for

Most glaucoma drops are well-tolerated. But some cause changes you should know about.

Prostaglandin analogues (bimatoprost, travoprost, latanoprost) can darken the iris over time in some patients, and may cause eyelash growth or mild redness. These are cosmetic and not dangerous — but tell your doctor.

Beta-blockers (timolol) can slow your heart rate and cause breathlessness in patients with asthma or heart disease. If you feel unusually short of breath or very tired after starting drops, contact your doctor the same day.

Alpha agonists (brimonidine) sometimes cause an allergic reaction with marked redness and discharge, usually within weeks of starting. Stop the drop and call your doctor if this happens.

None of these mean you must stop treatment. They mean the treatment may need adjustment.


Month 1–2 of Glaucoma Diagnosis: Tell Your Family

Your siblings and children need an eye check — now

Glaucoma has a strong genetic component. First-degree relatives of a glaucoma patient have a four to nine times higher risk of developing the disease. Most of them will have no symptoms at all until damage is advanced.

Tell your siblings and adult children this week. Ask them to see an ophthalmologist for a baseline pressure check, optic nerve assessment, and field test. This is not alarmist. It is the most useful thing your diagnosis can do for your family.


Month 1–3: Address the Controllable Risk Factors

Stop smoking — this one is not negotiable

Smoking constricts blood vessels and reduces blood flow to the optic nerve. It worsens the vascular risk that many glaucoma patients already carry. The damage from smoking adds to the damage from pressure — and your nerve cannot absorb both.

If you smoke, speak to your doctor about cessation support. This is as important as the drops.

Get your metabolic parameters checked

High blood pressure, diabetes, thyroid disease, and sleep apnoea all affect glaucoma progression through vascular and metabolic pathways. If these are uncontrolled, your optic nerve faces risk from two directions simultaneously.

Ask your physician to check your blood pressure, fasting glucose, HbA1c, and thyroid function if these have not been done recently. If you snore heavily or feel exhausted in the mornings, mention it — untreated sleep apnoea is a recognised glaucoma risk factor that is almost always missed.

Exercise — the right kind

Moderate aerobic exercise (brisk walking 30 minutes, five days a week) lowers intraocular pressure by a clinically meaningful amount in most patients. Avoid high-resistance head-down exercises like heavy weightlifting or inverted yoga poses — these transiently spike IOP.


Month 2–3: Ask About Laser Treatment

SLT — Selective Laser Trabeculoplasty

If your glaucoma is open-angle type, your doctor may recommend SLT as a first-line treatment or as a supplement to drops. SLT uses a laser to improve fluid drainage from the eye. It is done in the clinic in five to ten minutes, is painless, and works in approximately 75 to 80% of patients.

The effect lasts three to five years and can be repeated. SLT does not burn tissue — it sends a gentle energy pulse that stimulates the drainage cells to work better.

Ask your doctor at the 30-day or 90-day visit: “Am I a candidate for SLT?”

LPI — Laser Peripheral Iridotomy

If your glaucoma is narrow-angle or angle-closure type, LPI is a preventive procedure that creates a small opening in the iris to prevent a sudden pressure spike (acute angle-closure attack). LPI is typically recommended before an attack happens — it takes three to four minutes per eye and prevents one of the most painful ophthalmic emergencies.

If your doctor mentioned narrow angles at any point, ask specifically whether you need LPI. Do not wait.


Throughout: Keep Your Perspective

Do not search the internet at 2am

Glaucoma outcomes in treated patients are overwhelmingly good. The disease moves slowly in the vast majority of cases. Patients who take their drops, attend follow-ups, and manage their risk factors maintain useful vision for life in most cases.

The stories of severe vision loss you will find online mostly involve patients who were never diagnosed, or who stopped treatment. You are neither.

Reach out if you need support

A new diagnosis changes how you think about your body. Some patients find this unsettling, and that is entirely normal. Several Indian and international glaucoma patient forums, and online communities run by ophthalmologists offer peer support from people at every stage of the same journey.

You do not have to figure this out alone.


Your 90-Day Checklist

  • Eye drop technique confirmed by a doctor or technician
  • Alarm set — every day, same time
  • All reports photographed and filed digitally
  • 30-day follow-up appointment booked
  • Side effects list saved on your phone
  • Siblings and adult children informed and booked for screening
  • Smoking cessation initiated if applicable
  • Blood pressure, glucose, HbA1c, thyroid checked
  • SLT or LPI discussion had with your doctor
  • One support resource bookmarked

Frequently Asked Questions

Do I have to take eye drops for life?

In most cases, yes. Glaucoma is a chronic condition and eye drops control pressure — they do not cure the disease. Stopping drops allows pressure to rise again and damage to resume. Some patients reduce or stop drops after successful laser treatment (SLT), but this is a decision made with your doctor based on your pressure readings, not independently.

What if I forget a drop one day?

Take it as soon as you remember, unless it is almost time for the next dose. Do not double up. One missed dose will not cause a crisis. A habit of casual misses will. Reset the alarm and continue.

Can I drive after putting in my eye drops?

Most glaucoma drops do not affect vision significantly. Some patients notice mild blurring for a few minutes immediately after instillation — wait for this to clear before driving. If your doctor has dilated your pupils at a clinic visit, do not drive until dilation wears off, typically three to four hours.

My pressure was normal at diagnosis. Do I still have glaucoma?

Yes — this is called normal-tension glaucoma (NTG). Roughly 30 to 40% of glaucoma patients in India have pressures within the statistical normal range. The diagnosis is made on optic nerve appearance and visual field changes, not pressure alone. NTG is treated the same way — the target is to lower pressure further from your individual baseline.

Is glaucoma hereditary? Do I need to tell my family?

Yes, and yes. First-degree relatives — parents, siblings, children — have a four to nine times higher risk. Most will have no symptoms. Tell them this week and ask them to see an ophthalmologist for a baseline check that includes pressure, nerve assessment, and a visual field test.

Will I go blind?

Treated glaucoma in a compliant patient who attends follow-up carries a very low risk of blindness. The risk is real only when the disease is undiagnosed, undertreated, or ignored. You have been diagnosed. That is the most important step already taken.

What is SLT and should I ask about it?

Selective Laser Trabeculoplasty (SLT) is a five-minute clinic procedure that improves fluid drainage from the eye. It works in approximately 75 to 80% of open-angle glaucoma patients and can reduce or eliminate the need for drops for three to five years. Ask your doctor at the 30-day visit whether you are a candidate.

Can I exercise with glaucoma?

Yes — moderate aerobic exercise is actively beneficial and lowers IOP. Brisk walking, cycling, and swimming are all good. Avoid heavy resistance training with breath-holding (Valsalva manoeuvre) and inverted positions, both of which spike pressure transiently. If exercise is a regular part of your routine, tell your doctor so they can factor it into your pressure readings.

My drops are making my eyes red. Should I stop?

Do not stop without speaking to your doctor first. Redness is common with several drop classes and is often manageable — a preservative-free formulation or a switch in medication resolves it in most cases. Stopping drops independently allows pressure to rise. Call the clinic and describe the symptom.

How often will I need follow-up forever?

Once stable on treatment, most patients are reviewed every three to six months. This includes a pressure check and, once yearly or more often if needed, a repeat visual field test and OCT nerve scan to confirm the disease is not progressing. Glaucoma never becomes self-managing — the follow-up rhythm continues for life, but it is not onerous once the initial titration phase is complete.


This page is part of the Glaucoma Hub hub. Read about our full approach to glaucoma care and monitoring. Please also read our guide to Understanding Your Visual Field Test. You may want to read a patient’s experience with glaucoma eye drops, and of one with SLT.


About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1500+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google


Glaucoma Laser To Avoid Eye Drops

Selective Laser Trabeculoplasty (SLT) is a safe, non-invasive glaucoma laser treatment that can help lower eye pressure and reduce or delay the need for daily eye drops in selected patients. Early treatment decisions in glaucoma are about long-term pressure control, preserving vision, and reducing treatment burden—not just avoiding medication.

Standard glaucoma management assumes patients can put eyedrops. Patients with severe rheumatoid arthritis, osteoarthritis, or neurological tremors frequently cannot accurately administer daily eye drops. Recognising these physical limitations is a clinical responsibility. Selective Laser Trabeculoplasty (SLT) serves as an elite, non-invasive primary or adjunctive intervention that lowers intraocular pressure and eliminates the physical burden of drop compliance entirely.


THE ARTHRITIC HAND

Selective Laser Trabeculoplasty (SLT) To Avoid Glaucoma Eye Drops

A 78-year-old grandmother sat in my examination chair, her pressures were not controlled despite using eye drops. She had come for a second opinion. I asked her if she has used her eye drops. She said yes.

I happened to look at her hands, severely twisted by advanced rheumatoid arthritis.

Can you show me how you put eyedrops? She said she wasn’t carrying hers. I handed her a bottle of lubricating eyedrops.

She looked at me with tears in her eyes. Despite her absolute best efforts, her fingers lacked the strength to squeeze the bottle cleanly. Half the medication ran down her cheek every time.

No wonder her intraocular pressures swung unpredictably. Her remaining optic nerve fibres were quietly at risk.

We discussed options then, and she said she wanted to come back in two weeks. I was ready to wait. I performed Selective Laser Trabeculoplasty — a gentle, non-invasive outpatient procedure that takes under ten minutes. The laser targets specific cells in the eye’s drainage network, stimulating the body’s natural cleanup response to improve fluid outflow. Her intraocular pressure dropped into the ideal target zone.

She left the clinic that day free from drop bottles for the first time in years.

True medical accessibility means tailoring the science to fit the physical reality of the person in front of you.

I was one of the first eye doctors in India to offer SLT, fresh after my training at the University of Geneva. Here is an old video of mine from 2011, explaining my treatment philosophy after SLT.

Watch the video here.


FAQs

Can SLT laser replace glaucoma eye drops?

For some patients, SLT (Selective Laser Trabeculoplasty) can reduce or delay the need for glaucoma eye drops. Others may still need drops later depending on eye pressure, glaucoma type, and long-term response.

Is SLT painful?

SLT is usually well tolerated. The procedure is performed in the clinic, takes only a few minutes, and most people experience little to no discomfort.

How long does SLT last?

The pressure-lowering effect of SLT can last months to years and varies between individuals. In some cases, the laser may be repeated if appropriate.

Does SLT cure glaucoma?

No. SLT does not cure glaucoma or restore vision already lost. Its role is to lower eye pressure and help reduce the risk of future glaucoma progression.

How does SLT laser work to lower eye pressure?

SLT delivers precise, low-energy pulses to the trabecular meshwork — the eye’s internal drainage system. The laser selectively targets pigmented cells, stimulating a natural renewal process that clears microscopic blockages and allows fluid to drain more freely. It does not damage surrounding healthy tissue.

Is SLT a permanent replacement for daily glaucoma drops?

For many patients, SLT successfully controls intraocular pressure for several years, reducing or eliminating the need for daily drops. The effect can diminish over time, but the gentle nature of the procedure allows it to be safely repeated. Your specialist will monitor pressure and advise accordingly.


This page is part of the Advanced Glaucoma Care hub. Read about the full spectrum of glaucoma diagnosis and treatment.


About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1500+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google


Glaucoma Care in Gurgaon

Glaucoma is the leading cause of irreversible blindness worldwide. It is a progressive optic nerve disease that can silently damage vision much before symptoms become obvious. Early diagnosis, OCT imaging, visual field testing, and long-term monitoring are essential to reducing the risk of irreversible vision loss.

Superspecialty glaucoma care means catching that damage early, tracking it precisely, and making treatment decisions that are built around your individual risk, not a standard protocol.

Glaucoma Care in Gurgaon: Diagnosis, Treatment, and Second Opinions

Most people who arrive at a glaucoma consultation did not expect to be there.

Perhaps a routine eye check flagged your optic nerve. Maybe a parent lost vision to glaucoma and you want to know your own risk. Perhaps you have been on drops for years and something still doesn’t feel right. Whatever brought you here, you are asking the right question at the right time, because in glaucoma, timing is everything.

The nerve fibres that glaucoma destroys do not regenerate. Vision lost to this disease does not return. But vision that has not yet been lost can almost always be protected, if the disease is identified accurately, monitored carefully, and managed by a specialist with the training to interpret what the tests are actually showing.

This is what superspecialty glaucoma care means in practice.


What Glaucoma Actually Is

Glaucoma is not a single disease. It is a family of conditions that share one defining feature: progressive damage to the optic nerve, the cable that carries visual information from your eye to your brain.

In most forms of glaucoma, elevated intraocular pressure — the fluid pressure inside the eye — is the primary driver of that damage. But pressure is not the whole story. Roughly a third of glaucoma patients have pressures that fall within the normal range. In these patients, the nerve is vulnerable for reasons that go beyond simple mechanics — vascular supply, structural anatomy, and systemic factors all play a role.

This is why glaucoma cannot be managed by pressure alone. It requires a trained eye on the nerve itself.

The most common forms of glaucoma

Primary open-angle glaucoma is the most prevalent form globally and in India. It develops slowly, painlessly, and without warning. By the time peripheral vision is affected, significant nerve damage has usually already occurred.

Normal tension glaucoma is systematically underdiagnosed in India. Patients with pressures in the normal range are often reassured and discharged — while damage continues. Identifying this condition requires looking beyond the pressure reading.

Angle-closure glaucoma is more common in Asian populations. It can present as a sudden, painful emergency — or develop slowly and silently in the chronic form. A detailed anterior segment assessment is essential to detect the anatomical risk before a crisis occurs.

Childhood and secondary glaucomas require specialist evaluation. Secondary glaucomas — arising from inflammation, steroid use, trauma, or systemic conditions — are frequently missed or mismanaged without subspecialty input.


Why Superspecialty Training Changes Outcomes

A general ophthalmologist is trained to detect glaucoma and initiate treatment. A fellowship-trained glaucoma subspecialist is trained to do something more precise: to distinguish true progression from test variability, to select the right intervention at the right disease stage, and to manage the full complexity of a condition that evolves over decades.

The difference becomes most visible in three situations.

When the diagnosis is uncertain. Glaucoma suspects — patients with suspicious optic nerves or borderline pressures who do not yet meet diagnostic criteria — require careful longitudinal monitoring. The decision of when to treat, and how aggressively, requires experienced clinical judgement.

When progression occurs despite treatment. Patients who worsen on drops are not simply non-compliant. They may have nocturnal pressure spikes, inadequate pressure targets, or structural vulnerability that requires a different therapeutic approach entirely.

When surgery is on the table. The glaucoma surgical landscape has changed significantly with the advent of MIGS — minimally invasive glaucoma surgery. Knowing when MIGS is appropriate, which device fits which patient, and when conventional filtration surgery remains the better option requires a surgeon who operates across the full spectrum.


What to Expect at This Practice

My approach to glaucoma care is built around four principles.

Catch it before it matters. Early detection requires looking beyond the standard pressure check — at the optic nerve structure, the retinal nerve fibre layer on OCT, and the visual field pattern over time. I look for the signal before the symptom.

Track it with precision. A single test is a photograph. Glaucoma management requires a series of photographs — read by someone who understands what change looks like, and what normal variation looks like. I review trends, not snapshots.

Treat it at the right stage. Not every glaucoma patient needs surgery. Not every glaucoma patient can be managed on drops alone. The treatment plan is built around your disease stage, your lifestyle, your pressure target, and your individual risk of progression.

Protect the ocular surface. Long-term glaucoma drops affect the surface of the eye in a significant proportion of patients. Ocular surface disease reduces comfort, affects adherence, and is frequently undertreated. I address it as part of glaucoma management — not as a separate problem.

Glaucoma Care Covered in This Practice

Diagnosis and Detection

Medical Management

Monitoring and Progression

Surgery

Local and General

When to Come In

Book a superspecialty consultation if any of the following apply:

  • You have been told your optic nerve looks “suspicious” or “cupped”
  • You have a parent or sibling with glaucoma
  • You are on glaucoma drops and have never had a formal progression assessment
  • Your visual fields are worsening despite treatment
  • You have been recommended surgery and want a second opinion
  • You have high myopia — a significant independent risk factor for glaucoma
  • You use steroid drops, inhalers, or nasal sprays regularly

Glaucoma does not announce itself. By the time you notice something is wrong, the window for easy intervention may already be narrowing. Early assessment costs very little. Late diagnosis costs vision.


Frequently Asked Questions

What is the difference between a glaucoma specialist and a general eye doctor?

A glaucoma specialist has completed a dedicated fellowship — one to two years of focused training in glaucoma diagnosis, medical management, laser, and surgery — beyond standard ophthalmology residency. This training matters most in uncertain diagnoses, complex progression, and surgical planning.

How often should I have my eyes checked if I have glaucoma?

Most patients with established glaucoma require review every three to six months, including IOP measurement, OCT, and periodic visual field testing. The exact frequency depends on your disease stage, stability, and treatment response. Suspects require annual or biannual monitoring.

Can glaucoma be cured?

Glaucoma cannot currently be cured — but in the vast majority of patients, it can be controlled well enough to preserve functional vision for life. The key is early detection, accurate monitoring, and treatment that is adjusted as the disease evolves.

Is glaucoma hereditary?

Yes. First-degree relatives of glaucoma patients have a four to nine times higher risk of developing the condition. Screening siblings and adult children of affected patients is one of the most cost-effective interventions in glaucoma prevention.

What is MIGS and am I a candidate?

MIGS — minimally invasive glaucoma surgery — is a family of procedures designed to lower eye pressure with a safer profile than traditional filtration surgery. It is most appropriate for mild to moderate glaucoma. Not every patient is a candidate; appropriate selection requires subspecialty assessment.

You may want to listen to Dr Bhartiya answer some frequently asked questions here.


About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1500+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation for glaucoma

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google


Here are some patient stories

The English Teacher Who Began Painting Again

How to do visual fields

Uveitic glaucoma

Advanced Glaucoma Care in Gurgaon

Looking for advanced glaucoma care in Gurgaon? Dr Shibal Bhartiya provides expert diagnosis, risk stratification, second opinions, and long-term glaucoma management focused on preserving vision safely over time. Glaucoma can progress silently even when vision feels normal. Advanced glaucoma care combines detailed testing, risk stratification, continuity of follow-up, and individualized treatment planning to reduce the risk of preventable vision loss.

Advanced glaucoma care in Gurgaon requires more than a pressure check and a prescription. It requires structural analysis, individualised progression mapping, and a specialist with the training to catch damage before your vision notices it. That specialist should have fellowship-level expertise -not just general ophthalmology experience.

Most patients arrive at a glaucoma consultation after one of two experiences: a routine eye test that flagged something unexpected, or months of treatment that doesn’t feel like it’s working. Both are disorienting. Glaucoma is a condition where the stakes are permanent, lost nerve fibres do not return, and yet most early-stage patients feel completely normal. That gap between invisibility and irreversibility is exactly why the quality of your specialist matters more than in almost any other eye condition.

This page is not a list of credentials. It is a plain-language explanation of what advanced glaucoma management actually involves, so you can ask the right questions, in any clinic, including mine.


What Makes Glaucoma Management Genuinely Complex

Glaucoma is not one disease. It is a family of conditions: each with different pressure profiles, different structural signatures, and different rates of progression. Managing it well requires training that goes beyond what a general ophthalmologist receives.

Pressure is necessary, but not sufficient

Intraocular pressure (IOP) is the most controllable risk factor in glaucoma. But roughly 30–40% of glaucoma patients in India have pressures that fall within the “normal” range. A specialist who treats only the number, and misses the nerve, will miss the disease.

Structural progression requires trained interpretation

OCT (optical coherence tomography) scans generate data that is only as useful as the clinician reading it. Retinal nerve fibre layer thinning, ganglion cell loss, and optic disc changes must be interpreted in the context of your age, disc anatomy, and longitudinal trend. A single scan means very little. A series of scans, read by someone who knows what they are looking for, means everything.

24-hour IOP behaviour matters

IOP fluctuates across the day and night. A single clinic reading captures one moment. Fellowship-trained glaucoma specialists are trained to account for diurnal variation, peak pressure timing, and nocturnal dips: factors that can determine whether a patient progresses despite apparently controlled pressures. This is an area where I have published peer-reviewed research.

Treatment decisions are not linear

Drops, laser, MIGS (minimally invasive glaucoma surgery), and filtration surgery each have a specific place in a well-structured management plan. Choosing the right intervention, and the right sequence, requires experience with the full treatment spectrum, not just the tools a particular clinic happens to offer.


What to Look For When Choosing a Glaucoma Specialist in Gurgaon

This is the question most patients search for but rarely find answered honestly. Here is what actually differentiates a glaucoma subspecialist from a general eye doctor offering glaucoma care.

What to AskWhy It MattersWhat to Look For
Did the doctor complete a glaucoma fellowship?Fellowship training means 1–2 years of dedicated subspecialty immersion beyond residencyLook for fellowship credentials, not just MBBS + MS
Does the clinic offer 24-hour IOP monitoring?Single readings miss nocturnal pressure spikes that drive progressionAsk whether phasing or ambulatory IOP is available
Can the doctor interpret OCT trends across time?Structural progression is subtle and cumulativeAsk how many scans are needed before they track trends
Is MIGS offered — and appropriately selected?MIGS is not appropriate for every patient; over-recommendation is a red flagA good specialist will tell you when surgery is not yet needed
Does the specialist publish research?Research engagement means currency with evolving evidenceCheck PubMed, ORCID, or academic profiles

What Doctors Often Miss in Glaucoma Consultations

In over 25 years of glaucoma practice, these are the patterns I see most often in patients who arrive for a second opinion.

Normal pressure, missed diagnosis. Normal tension glaucoma is systematically underdiagnosed in India. Patients with pressures of 14–16 mmHg are reassured and discharged — while nerve fibre loss continues silently.

OCT reported as “stable” without longitudinal comparison. A single OCT is a photograph. Stability can only be determined by comparing photographs across time. Patients are sometimes told they are stable after one scan.

Ocular surface disease from drops, untreated. Long-term use of preserved glaucoma drops causes surface inflammation in a significant proportion of patients. This is rarely addressed proactively — and yet it affects adherence, comfort, and outcomes directly.

MIGS offered too early or too late. Minimally invasive glaucoma surgery has transformed the moderate-stage treatment window. But it is not a substitute for medical therapy in early disease, and it is insufficient for advanced disease. Appropriate patient selection is a subspecialty skill.

Family history not taken seriously. First-degree relatives of glaucoma patients have a 4–9x elevated risk. Screening of siblings and children is rarely initiated proactively.


When to Seek a Second Opinion

Seek a second opinion if any of the following apply:

  • You have been on the same drops for more than two years with no formal progression assessment
  • Your visual field tests show worsening despite treatment
  • You were told your pressures are normal but your optic nerve looks “suspicious”
  • Surgery has been recommended and you want to understand all your options
  • You have a strong family history and want a baseline assessment from a subspecialist

A second opinion is not disloyalty to your current doctor. In a condition where the damage is permanent and irreversible, it is due diligence.


What This Means for You

If you are searching for the best glaucoma care in Gurgaon, the most important thing you can do is not look for a superlative — it is to look for a subspecialist. Fellowship training, peer-reviewed research, and a structured approach to progression monitoring are the markers that distinguish subspecialty glaucoma care from general ophthalmology practice.

I am a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience managing glaucoma across its full spectrum — from early suspect to advanced disease requiring surgical intervention. My practice at Marengo Asia Hospitals, Sector 56, Gurugram is built around catching damage before it becomes irreversible, and around ensuring that every treatment decision is grounded in your individual risk profile — not a protocol.

If you would like a structured assessment or a second opinion on your current management, I am available for consultation.

📞 +91 88826 38735 | 🌐 www.drshibalbhartiya.com


Frequently Asked Questions

How do I choose the best glaucoma specialist in Gurgaon?

Look for a doctor who completed a dedicated glaucoma fellowship — not just general ophthalmology training. The best glaucoma specialists offer structural progression monitoring with OCT, account for 24-hour pressure behaviour, and have experience across the full treatment spectrum including MIGS and filtration surgery. Research publications are a reliable indicator of subspecialty currency.

What is the difference between a glaucoma specialist and a general eye doctor?

A glaucoma specialist has completed additional fellowship training — typically one to two years — focused exclusively on glaucoma diagnosis, medical management, laser, and surgery. A general ophthalmologist can manage straightforward cases but may lack the training to detect subtle progression, interpret complex OCT trends, or select patients appropriately for MIGS.

Is Dr Shibal Bhartiya the best glaucoma doctor in Gurgaon?

Dr Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience and 90+ PubMed-indexed publications. She offers subspecialty glaucoma care including second opinions, advanced surgical options including MIGS, and 24-hour IOP assessment at Marengo Asia Hospitals, Sector 56, Gurugram. Patients are encouraged to review her published research and make their own assessment.

What should I look for when seeking the best doctor for MIGS surgery in Gurgaon?

MIGS, minimally invasive glaucoma surgery, requires a surgeon with specific training in device selection, patient eligibility assessment, and intraoperative technique. Ask whether your surgeon has published on MIGS outcomes, can explain why you are or are not a candidate, and offers filtration surgery as an alternative if MIGS is insufficient for your disease stage.

Can I get a glaucoma second opinion in Gurgaon?

Yes. Second opinions for glaucoma are available at Marengo Asia Hospitals, Sector 56, Gurugram. Bring your previous OCT scans, visual field reports, and current prescription to your appointment. A structured second opinion typically includes a full structural assessment, pressure evaluation, and review of your current management plan.


About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1500+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation for glaucoma

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google


Which Is the Best Eyedrop for Glaucoma?

No single “best” eye drop exists for everyone. That said, prostaglandin analogs (like bimatoprost or travoprost) are usually the first-line…